Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
about
N-linked glycan profiling in neuroblastoma cell lines.Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia.Metabolic glycoengineering sensitizes drug-resistant pancreatic cancer cells to tyrosine kinase inhibitors erlotinib and gefitinib.Metabolic Remodeling of Cell-Surface Sialic Acids: Principles, Applications, and Recent Advances.Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines.Correction: Sialic Acid Metabolic Engineering: A Potential Strategy for the Neuroblastoma Therapy.Metabolic Glycoengineering of Sialic Acid Using N-acyl-modified Mannosamines.
P2860
Q35892304-28B85129-916F-4348-8EF7-D239765C321EQ37644988-9E4D1263-C435-40ED-857C-226BDD1A2B3FQ38301000-2A98BB96-6857-490F-A969-81C6C60CD3B0Q38634704-AF75B406-6153-4C3C-BA47-5187B3B49344Q38902441-D4AB92FA-17B8-454C-AF93-F90BF89FB3E5Q42558404-31F3C506-295F-449F-8F0E-AD79032BC009Q49498172-4ACEADB5-B57C-4784-9ABC-E9933281E298
P2860
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@ast
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@en
type
label
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@ast
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@en
prefLabel
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@ast
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@en
P2093
P2860
P1433
P1476
Sialic acid metabolic engineering: a potential strategy for the neuroblastoma therapy.
@en
P2093
Christina E Galuska
Christoph Kannicht
Dagobert Glanz
Dirk Vordermark
Guido Kohla
Manimozhi Nagasundaram
Matthias Bache
Roland Schauer
Rüdiger Horstkorte
P2860
P304
P356
10.1371/JOURNAL.PONE.0105403
P407
P577
2014-08-22T00:00:00Z